Insider Holders & Insider Ownership - Emergent BioSolutions Inc. (EBS)

List of insiders holdings for Emergent BioSolutions Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
El-Hibri Fuad
Director
2021-12-07 21:10:111,136,971
3,706,442
4,843,413Form 4
Intervac L.L.C.
10% Owner
2012-09-20 20:20:014,494,250
0
4,494,250Form 4
Microscience Investments LTD
Member of 13(d) group
10% Owner
2007-03-16 14:18:243,636,801
0
3,636,801Form 13G
BIOPHARM L.L.C.
10% Owner
2010-06-01 16:12:282,965,043
0
2,965,043Form 4
Myers Robert Calvin
Member 13(d) group owning >10%
2007-02-14 12:43:522,394,045
0
2,394,045Form 13G
Biovac L.L.C.
13(d) group member, owns > 10%
2007-02-14 12:30:521,599,155
0
1,599,155Form 13G
JP MORGAN PARTNERS BHCA LP
JP MORGAN PARTNERS GLOBAL INVESTORS LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
J P MORGAN PARTNERS GLOBAL INVESTORS A LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P
JPMP MASTER FUND MANAGER L P
JPMP GLOBAL INVESTORS L P
JPMP CAPITAL CORP
Member of 13(d) group
2007-03-19 11:32:581,454,418
0
1,454,418Form 3
Biologika L.L.C.
Member 13(d) group owning >10%
2008-06-06 18:11:331,399,764
0
1,399,764Form 4
Michigan Biologic Products Inc.
Member 13(d) group owning >10%
2008-03-28 20:17:571,269,390
0
1,269,390Form 4
Kramer Robert
President and CEO
2023-06-13 21:20:241,041,110
0
1,041,110Form 4
ADVENT PRIVATE EQUITY FUND III A LTD PARTNERSHIP
Member of 13(d) Group
2007-06-29 17:08:51925,537
0
925,537Form 13G
PAPA JOSEPH C
President and CEO
2024-03-15 17:16:43750,000
0
750,000Form 4
Intervac Management L.L.C.
13(d) group member, owns > 10%
2007-02-14 12:39:25719,275
0
719,275Form 13G
ARPI L.L.C.
13(d) group member, owns > 10%
2007-02-14 12:20:25658,254
0
658,254Form 13G
Mulligan Seamus
Director
2019-03-21 16:18:1256,141
545,590
601,731Form 4
Merlin General Partner II LTD (as General Partner of the Merlin Biosciences Fund L.P.)
Member of 13(d) group
2007-03-12 19:21:48498,722
0
498,722Form 3
Havey Adam
EVP, Business Operations
2023-06-13 21:20:59336,304
0
336,304Form 4
ADVENT PRIVATE EQUITY FUND III B LTD PARTNERSHIP
Member of 13(d) Group
2007-03-12 19:58:34229,497
0
229,497Form 3
Fox Jennifer Lynne
EVP, Ext Aff, GC, Corp Sec
2024-07-12 16:33:12186,382
0
186,382Form 4
LINDAHL RICHARD S
EVP, Chief Financial Officer
2024-10-17 17:04:36171,009
0
171,009Form 4
Glessner Coleen
EVP, Quality & Ethics, and CPL
2024-06-11 16:10:33163,134
0
163,134Form 4
Fowler Neal Franklin
Director
2024-05-28 21:41:15161,848
0
161,848Form 4
Abdun-Nabi Daniel
CEO
2019-03-04 18:39:36142,617
1,936
144,553Form 4
SULLIVAN LOUIS W
Director
2024-05-28 21:14:55130,443
0
130,443Form 4
ADVENT PRIVATE EQUITY FUND III D LTD PARTNERSHIP
Member if a 13(d) Group
2007-03-12 20:00:49125,921
0
125,921Form 3
Arcuri Edward
COO
2007-05-10 11:04:35115,083
0
115,083Form 4
Harsanyi Zsolt
Chairman
2024-05-28 21:14:42115,077
0
115,077Form 4
DeGolyer Donald W
Director
2024-11-14 16:18:57111,100
0
111,100Form 4
Richard Ronald
Director
2024-05-28 21:14:1796,862
0
96,862Form 4
Dayal Sujata Tyagi
Director
2024-05-28 21:40:3488,877
0
88,877Form 4
SARAN ATUL
EVP, Chief Strat & Dev Officer
2023-03-02 14:43:1286,645
0
86,645Form 4
Katkin Keith
Director
2024-05-28 21:41:2985,620
0
85,620Form 4
ADVENT PRIVATE EQUITY FUND III C LTD PARTNERSHIP
Member of 13(d) Group
2007-03-12 19:59:4964,018
0
64,018Form 3
Strei Katherine
EVP, Chief HR Officer
2023-03-02 14:42:2362,824
0
62,824Form 4
Hauer Jerome M
Director
2023-05-30 19:08:3957,508
0
57,508Form 4
Zoon Kathryn C
Director
2024-06-06 16:16:2054,482
0
54,482Form 4
White Marvin L
Director
2024-11-13 16:04:5054,092
0
54,092Form 4
Hartzel William
SVP, Bioservices
2024-11-13 16:04:3947,475
0
47,475Form 4
Perl Jessica
SVP, General Counsel, Corp Sec
2024-11-12 16:26:1440,250
0
40,250Form 3
JOULWAN GEORGE A
Director
2022-05-31 16:20:5740,244
0
40,244Form 4
Keese Kyle
EVP, BioSciences Division
2011-03-17 15:31:4339,954
0
39,954Form 4
Elsey R Don
Chief Financial Officer
2012-03-16 15:06:1338,914
0
38,914Form 4
Emergent BioSolutions Inc.
Sean Kirk, EVP, Manufacturing
2019-06-03 21:13:4336,624
0
36,624Form 3
Niederhuber John
Director
2016-05-23 08:39:3630,300
0
30,300Form 4/A
Merlin General Partner II LTD (as Managing Partner of the Merlin Biosciences Fund Gbr)
Member of 13(d) group
2007-03-12 19:19:1929,972
0
29,972Form 3
Chatfield Steven
EVP, BioSciences
2013-03-18 14:11:1328,000
0
28,000Form 4
Esposito Denise
CLO
2009-03-12 14:38:0027,300
0
27,300Form 4
Labinger Barry
EVP, Biosciences Div.
2015-11-17 17:15:4025,182
0
25,182Form 4
Bailey Sue
Director
2021-03-08 18:30:5624,427
0
24,427Form 4
Williams Paul Anthony
SVP, Products Business
2024-07-10 16:02:4124,333
0
24,333Form 4
ADVENT PRIVATE EQUITY FUND III GMBH & CO KG
Member of 13(d) Group
2007-03-12 20:08:2218,118
0
18,118Form 3
Kirk Sean
EVP, Manufacturing & Tech Ops
2021-04-01 18:54:1617,776
0
17,776Form 4
ADVENT PRIVATE EQUITY FUND III AFFILIATES
Member of 13 (d) Group
2007-03-12 20:01:4915,098
0
15,098Form 3
ALLBAUGH JOE M
Director
2008-05-23 10:13:4914,400
0
14,400Form 4
Malik Shahzad
Director
2007-06-18 19:15:1214,400
0
14,400Form 4
LOCKHART STEPHEN
SVP Product Development
2010-11-16 15:13:1112,813
0
12,813Form 4
Smith Karen L.
EVP, Chief Medical Officer
2021-05-11 16:30:1111,888
0
11,888Form 4
ADVENT MANAGEMENT III L P
Member of 13(d) Group
2007-03-12 20:07:214,530
0
4,530Form 3
Zink Thomas
SVP & CMO
2007-05-21 15:41:581000
0
1000Form 4
Lowry Simon C
SVP, R&D, CMO
2024-11-21 16:02:400
0
0Form 3
APAX EUROPE IV GP CO LTD
Member of 13(d) group
2008-10-17 11:12:090
0
0Form 13G
Gibellini Mauro
SVP, Corporate Dev.
2007-06-06 15:10:320
0
0Form 4
MILLER H HAYWOOD III
Interim CEO
2023-07-18 18:22:140
0
0Form 3